BioSpace News Archive

Growing acceptance of non-invasive monitoring techniques in the worldwide healthcare sector for ventilation and oxygenation is likely to promote the growth of the global transcutaneous monitors market in the assessment period 2020–2030.

Neglected tropical diseases refer to a group of tropical infections that are common in the low-income communities of major developing countries such as Asia and Africa.

Ketotifen Fumarate is the fumarate salt of ketotifen, a cycloheptathiophene analog with anti-allergic action. Ketotifen inhibits histamine (H1) receptors selectively and avoids usual effects caused by the release of histamine.

The rising prevalence of neurological, cardiac, and various other anomalies will help promote the growth of the global immunoadsorption columns market.

Friedreich ataxia is a rare inherited disease leading to progressive nervous system damage and issues in movement. The disease begins in childhood resulting into the impairment of muscle coordination that might get worse over time.

Cold plasma isn’t in thermodynamic balance either because of distinction in particle and electron temperature or if speed dispersion of species does not take after Maxwell Boltzmann circulation.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global gamma probe devices market is projected to exhibit a CAGR of 10% during the forecast period between 2020 to 2030, predicts Fact.MR.

Masimo announced the findings of a prospective study published in Anesthesia & Analgesia in which Dr. Claudia Spies and colleagues investigated the relationship between parameters derived from electroencephalogram spectra, measured using Masimo SedLine® Brain Function Monitoring, and postoperative delirium in older patients undergoing elective surgery.

Memo Therapeutics AG, an innovator in the field of antibody discovery and development, announced the receipt of CHF10.5 million from the Swiss Federal Funding Programme for COVID-19 Medicines to clinically develop COVAB 36, a potent, fully-human monoclonal antibody for the treatment of SARS-CoV-2 infections.

Altimmune, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for obesity and liver diseases, announced the appointment of Richard Eisenstadt as Chief Financial Officer, effective December 31, 2021.